Connect your AI

Aurinia Pharmaceuticals AUPH Earnings yield

Earnings yield at other companies

Rogers CorporationROG

-3.2%-4.6pp

Vera TherapeuticsVERA

-12.9%+1.8pp

ANI PharmaceuticalsANIP

5.3%+4.4pp

Ultragenyx PharmaceuticalRARE

-29.6%+144pp

Agios PharmaceuticalsAGIO

-21.3%—

Kiniksa Pharmaceuticals International, plcKNSA

2%+1.5pp

Other financials

Income statement

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

Operating cash flow$32.6M+2,405%

Valuation

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

net income/market cap=15.1%

Based on trailing twelve months.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Aurinia Pharmaceuticals's earnings yield?: Aurinia Pharmaceuticals (AUPH) reported earnings yield of 15.1% in Q1 2026.
How has Aurinia Pharmaceuticals's earnings yield changed year-over-year?: Aurinia Pharmaceuticals's earnings yield increased by 319.4% year-over-year, from 3.6% to 15.1%.
What is the long-term trend for Aurinia Pharmaceuticals's earnings yield?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's earnings yield has grown at a 21.3% compound annual growth rate (CAGR), from -5.2% to 13.7%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.